Vor Biopharma Inc [NASDAQ: VOR] plunged by -$0.07 during the normal trading session on Thursday and reaching a high of $2.005 during the day while it closed the day at $1.93.
Vor Biopharma Inc stock has also loss -3.50% of its value over the past 7 days. However, VOR stock has inclined by 743.90% in the 3 months of the year. Over the past six months meanwhile, it has gained 114.44% and gained 120.77% year-on date.
The market cap for VOR stock reached $244.50 million, with 125.65 million shares outstanding and 68.23 million shares in the current float. Compared to the average trading volume of 18.15M shares, VOR reached a trading volume of 4778223 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Vor Biopharma Inc [VOR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VOR shares is $1.18 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VOR stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Vor Biopharma Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 30, 2025. While these analysts kept the previous recommendation, Wedbush raised their target price to Outperform. The new note on the price target was released on July 26, 2022, representing the official price target for Vor Biopharma Inc stock. Previously, the target price had yet another raise to $6, while Goldman analysts kept a Neutral rating on VOR stock.
VOR stock trade performance evaluation
Vor Biopharma Inc [VOR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.50. With this latest performance, VOR shares dropped by -11.47% in over the last four-week period, additionally plugging by 114.44% over the last 6 months – not to mention a rise of 73.87% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VOR stock in for the last two-week period is set at 46.39, with the RSI for the last a single of trading hit 0.18, and the three-weeks RSI is set at 0.22 for Vor Biopharma Inc [VOR]. The present Moving Average for the last 50 days of trading for this stock 2.03, while it was recorded at 1.99 for the last single week of trading, and 1.13 for the last 200 days.
Vor Biopharma Inc (VOR) Capital Structure & Debt Analysis
Vor Biopharma Inc (VOR) Efficiency & Liquidity Metrics
Vor Biopharma Inc (VOR) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Vor Biopharma Inc. (VOR) effectively leverages its workforce, generating an average of -$10468113.21 per employee. The company’s liquidity position is robust, with a Current Ratio of 3.49% and a Quick Ratio of 3.49%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for Vor Biopharma Inc [VOR] stock
With the latest financial reports released by the company, Vor Biopharma Inc posted -0.4/share EPS, while the average EPS was predicted by analysts to be reported at -0.4/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VOR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Vor Biopharma Inc go to 17.49%.
Vor Biopharma Inc [VOR]: Institutional Ownership
There are presently around $43.61%, or 74.17%% of VOR stock, in the hands of institutional investors. The top three institutional holders of VOR stocks are: RA CAPITAL MANAGEMENT, L.P. with ownership of 22.75 million shares, which is approximately 33.439%. FMR LLC, holding 7.08 million shares of the stock with an approximate value of $$7.08 million in VOR stocks shares; and FMR LLC, currently with $$6.46 million in VOR stock with ownership which is approximately 9.4917%.
